1. Home
  2. MTSI vs SNN Comparison

MTSI vs SNN Comparison

Compare MTSI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSI
  • SNN
  • Stock Information
  • Founded
  • MTSI 1950
  • SNN 1856
  • Country
  • MTSI United States
  • SNN United Kingdom
  • Employees
  • MTSI N/A
  • SNN N/A
  • Industry
  • MTSI Semiconductors
  • SNN Industrial Specialties
  • Sector
  • MTSI Technology
  • SNN Health Care
  • Exchange
  • MTSI Nasdaq
  • SNN Nasdaq
  • Market Cap
  • MTSI N/A
  • SNN 11.0B
  • IPO Year
  • MTSI 2012
  • SNN 1999
  • Fundamental
  • Price
  • MTSI $136.21
  • SNN $23.89
  • Analyst Decision
  • MTSI Strong Buy
  • SNN Strong Buy
  • Analyst Count
  • MTSI 10
  • SNN 1
  • Target Price
  • MTSI $128.00
  • SNN N/A
  • AVG Volume (30 Days)
  • MTSI 594.4K
  • SNN 944.1K
  • Earning Date
  • MTSI 01-30-2025
  • SNN 02-25-2025
  • Dividend Yield
  • MTSI N/A
  • SNN 3.14%
  • EPS Growth
  • MTSI N/A
  • SNN 39.77
  • EPS
  • MTSI 1.04
  • SNN 0.35
  • Revenue
  • MTSI $729,578,000.00
  • SNN $5,642,000,000.00
  • Revenue This Year
  • MTSI $26.74
  • SNN $6.24
  • Revenue Next Year
  • MTSI $10.96
  • SNN $4.92
  • P/E Ratio
  • MTSI $130.97
  • SNN $34.19
  • Revenue Growth
  • MTSI 12.52
  • SNN 5.48
  • 52 Week Low
  • MTSI $79.25
  • SNN $23.65
  • 52 Week High
  • MTSI $143.90
  • SNN $31.72
  • Technical
  • Relative Strength Index (RSI)
  • MTSI 53.32
  • SNN 31.04
  • Support Level
  • MTSI $129.35
  • SNN $24.36
  • Resistance Level
  • MTSI $141.89
  • SNN $24.82
  • Average True Range (ATR)
  • MTSI 3.82
  • SNN 0.28
  • MACD
  • MTSI -0.34
  • SNN -0.03
  • Stochastic Oscillator
  • MTSI 57.03
  • SNN 17.54

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: